EPFL researchers created an AI-driven microscopy system that predicts and analyzes misfolded protein aggregation in real time.
Key Details
- 1Developed a self-driving imaging system combining multiple microscopy methods and deep learning.
- 2System predicts and detects protein aggregation—a hallmark of neurodegenerative diseases—in living cells.
- 3Uses label-free microscopy to minimize sample alteration and maximize imaging efficiency.
- 4Upon aggregation detection, system triggers Brillouin microscope to analyze biomechanical properties of aggregates.
- 5Aggregation onset detection achieved 91% accuracy using a specialized deep learning algorithm.
- 6Published in Nature Communications, with potential impact on drug discovery and precision medicine.
Why It Matters
This work showcases how AI-driven, label-free imaging can reveal dynamic, disease-relevant cellular processes in unprecedented detail, opening new pathways for diagnostic research and drug development in neurodegenerative diseases.
Source
EurekAlert
Related News
•EurekAlert
Major Study Reveals Barriers to Implementing AI Chest Diagnostics in NHS Hospitals
A UCL-led study identifies significant challenges in deploying AI tools for chest diagnostics across NHS hospitals in England.
•EurekAlert
AI Model Enhances Prediction of Infection Risks from Oral Mucositis in Stem Cell Transplant Patients
Researchers developed an explainable AI tool that accurately predicts infection risks related to oral mucositis in hematopoietic stem cell transplant patients.
•EurekAlert
AI-Enabled Hydrogel Patch Provides Long-Term High-Fidelity EEG and Attention Monitoring
Researchers unveil a reusable hydrogel patch with machine learning capabilities for high-fidelity EEG recording and attention assessment.